Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 15531404)

1.

Cognitive deficits as treatment targets in schizophrenia.

Gold JM.

Schizophr Res. 2004 Dec 15;72(1):21-8.

PMID:
15531404
2.

Cognitive factors in schizophrenia: causes, impact, and treatment.

Meltzer HY.

CNS Spectr. 2004 Oct;9(10 Suppl 11):15-24.

PMID:
15475873
3.

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.

Sharma T, Antonova L.

Psychiatr Clin North Am. 2003 Mar;26(1):25-40. Review.

PMID:
12683258
4.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
5.

Cognitive rehabilitation with patients having persistent, severe psychiatric disabilities.

Lewis L, Unkefer EP, O'Neal SK, Crith CJ, Fultz J.

Psychiatr Rehabil J. 2003 Spring;26(4):325-31.

PMID:
12739903
6.

Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Braff DL, Light GA.

Psychopharmacology (Berl). 2004 Jun;174(1):75-85. Epub 2004 Apr 30.

PMID:
15118804
7.

Should cognitive deficit be a diagnostic criterion for schizophrenia?

Lewis R.

J Psychiatry Neurosci. 2004 Mar;29(2):102-13. Review.

8.

Correlates of cognitive deficits in first episode schizophrenia.

Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG.

Schizophr Res. 2004 May 1;68(1):1-9.

PMID:
15037334
9.

Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.

Kertzman S, Reznik I, Grinspan H, Weizman A, Kotler M.

Isr J Psychiatry Relat Sci. 2008;45(2):114-20. Review.

10.

Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

Hill SK, Schuepbach D, Herbener ES, Keshavan MS, Sweeney JA.

Schizophr Res. 2004 May 1;68(1):49-63.

PMID:
15037339
11.

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA.

Am J Psychiatry. 2000 Apr;157(4):549-59.

PMID:
10739413
12.
13.
14.

A brief cognitive assessment for use with schizophrenia patients in community clinics.

Velligan DI, DiCocco M, Bow-Thomas CC, Cadle C, Glahn DC, Miller AL, Biggs MM, Shores-Wilson K, McKenzie CA, Crismon ML.

Schizophr Res. 2004 Dec 1;71(2-3):273-83.

PMID:
15474898
15.

The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.

Good KP, Rabinowitz J, Whitehorn D, Harvey PD, DeSmedt G, Kopala LC.

Schizophr Res. 2004 May 1;68(1):11-9.

PMID:
15037335
16.

Neuropsychological impairments in patients with schizophrenia: stability and prediction of outcome.

Gråwe RW, Levander S.

Acta Psychiatr Scand Suppl. 2001;(408):60-4.

PMID:
11730074
17.

Does cognitive function improve with quetiapine in comparison to haloperidol?

Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL.

Schizophr Res. 2002 Jan 15;53(3):239-48.

PMID:
11738537
18.

Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.

Minzenberg MJ, Poole JH, Benton C, Vinogradov S.

Am J Psychiatry. 2004 Jan;161(1):116-24.

PMID:
14702259
19.

Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.

Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV.

Schizophr Res. 2003 Sep 1;63(1-2):49-58.

PMID:
12892857
20.

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.

Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL.

Am J Psychiatry. 1998 Aug;155(8):1080-6.

PMID:
9699697
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk